98%
921
2 minutes
20
Green equity index providers claim that they can play a central role in allocating capital towards decarbonization. This study verifies this claim by analysing the environmental performance of 20 MSCI equity indices comprising 5267 constituents in 50 countries over the period 2015-2022. In each region (the World, the U.S., Europe, Emerging Markets), we analyse four MSCI green indices, namely Climate Change (CC), Paris-Aligned Benchmark (PAB), Socially Responsible Investment (SRI), and SRI Filtered PAB (SRI PAB), relative to the MSCI standard index. Our aggregated index-level regression reveals that the green criteria employed by MSCI statistically and significantly contributed to CO emissions reductions for all examined green indices, and better environmental/ESG ratings for the CC, SRI, and SRI PAB indices. This relationship is robust to aggregated index-level control variables, various subsamples, and alternative emissions measures provided by Refinitiv, Bloomberg, and CDP. An investment of US$1000 in January 2015 in the CC, PAB, SRI, and SRI PAB indices (instead of the standard index) respectively resulted in an average reduction of 982 kg (-53 %), 1429 kg (-77 %), 1147 kg (-61 %), and 1355 kg (-73 %) CO emissions at the end of December 2022. The robust environmental outperformance of Paris Agreement-aligned indices suggests that they should be embedded in benchmark regulations and granted preferential capital treatment. Institutions should set low-carbon targets to guide asset managers towards green ETF investments to accelerate the low-carbon economy transition. Our study also stresses the importance of improving transparency, standardizing ESG performance metrics, and rating criteria to support green investing.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jenvman.2025.126022 | DOI Listing |
Indian Dermatol Online J
September 2025
Department of Dermatology, Sri Guru Harkrishan Sahib Sohana Hospital, Mohali, Punjab, India.
Indian Dermatol Online J
September 2025
Department of Dermatology and Sexually Transmitted Diseases, Sri Manakula Vinayagar Medical College and Hospital, Puducherry, India.
J Clin Invest
September 2025
Department of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, United Kingdom.
Understanding the genetic causes of diseases affecting pancreatic β cells and neurons can give insights into pathways essential for both cell types. Microcephaly, epilepsy and diabetes syndrome (MEDS) is a congenital disorder with two known aetiological genes, IER3IP1 and YIPF5. Both genes encode proteins involved in endoplasmic reticulum (ER) to Golgi trafficking.
View Article and Find Full Text PDFNaturwissenschaften
September 2025
Department of Biomedical Engineering, Sri Sivasubramaniya Nadar College of Engineering, Kalavakkam, 603110, Tamil Nadu, India.
Wounds with extensive tissue damage are highly susceptible for microbial infections delaying the process of wound healing. Currently, biomaterials with therapeutic molecules emerged as key players in wound repairing. This work developed a novel collagen-based hydrogel loaded with allicin and silver nanoparticles.
View Article and Find Full Text PDFMinerva Cardiol Angiol
September 2025
Department of Pharmacology, MGM Medical College and Hospital, MGM Institute of Health Sciences, Nerul, Navi Mumbai, India.
Liraglutide is a key therapeutic agent in managing type 2 diabetes mellitus (T2DM), with benefits extending beyond glycemic control to address cardiovascular and renal comorbidities. As T2DM prevalence rises globally, the need for medications that provide comprehensive health benefits becomes increasingly important. Liraglutide, a GLP-1 receptor agonist, has demonstrated effectiveness in reducing cardiovascular events, especially among patients with high cardiovascular risk, such as those with a prior history of myocardial infarction or stroke.
View Article and Find Full Text PDF